SHZ:300677

Intco Medical Technology Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:48 UTC

Last close

n/aCNY

Market data

  • 28.7xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed
    • Computed from the filing for 2025
  • 3.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 10.2%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -7.0%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.96Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.4%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed

Follow one yuan

lens 1 of 9
After what it costs to make
24.1%
After running the business
12.4%
After interest and tax
10.2%
After what it must reinvest
-7.0%
Kept after the dividend
-11.2%
after what it costs to make, 24.1% of sales; after running the business, 12.4% of sales; after interest and tax, 10.2% of sales; after what it must reinvest, -7.0% of sales; kept after the dividend, -11.2% of sales

The five stops

5 of 5 read
  • After what it costs to make2,394,263,72424.1%
  • After running the business1,230,170,95412.4%
  • After interest and tax1,010,699,97010.2%
  • After what it must reinvest-689,723,189-7.0%
  • Kept after the dividend-1,111,891,792-11.2%

Of every unit of sales, -0.11 is still there after the dividend.

Of every unit of sales, -0.11 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales9,925,819,444
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After what it costs to make2,394,263,724
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After running the business1,230,170,954
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After interest and tax1,010,699,970
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After what it must reinvest-689,723,189
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Kept after the dividend-1,111,891,792
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.